Biotech Involved in COVID-19, Neurodegenerative Diseases Reports Q3/20 Results
Source: Streetwise Reports  (11/12/20)
ProMIS Neurosciences formed two new joint ventures, one for developing tests for the detection, diagnosis and monitoring of Alzheimer's disease, and the second for serological assays for antibodies to the SARS-CoV-2 virus. More >

Individuals Succeed Using This Digital Therapy—Now It's Moving to Insurers
Source: Matt Badiali for Streetwise Reports  (11/10/20)
Independent financial analyst Matt Badiali profiles a digital therapeutics company that is changing diabetes treatment. More >

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports  (11/3/20)
Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue. More >

Exact Sciences Shares Rise 29% as Firm Announces Q3 Earnings, a Capital Raise and Two Acquisitions
Source: Streetwise Reports  (10/27/20)
Exact Sciences Corp. shares reached a new 52-week high after the maker of cancer screening test Cologuard reported Q3/20 financial results that included a greater than 86% increase in year-over-year revenue. More >

CareDx Shares Trade Up 15% After Announcing 57% YoY Increase in Q3 Revenue
Source: Streetwise Reports  (10/8/20)
CareDx shares established a new 52-week high after the company reported that preliminary revenue in Q3/20 increased 57% year-over-year to $53.0 million. More >

American Renal Associates Agrees to Private Equity Firm's $853 Million Buyout Offer
Source: Streetwise Reports  (10/2/20)
Shares of American Renal Associates traded 67% higher and set a new 52-week high after the company reported that it has entered into a definitive agreement to be acquired by a Nautic Partners LLC affiliate for $11.50 per share in cash. More >

Genetron Receives FDA Breakthrough Approval for Hepatocellular Carcinoma Detection Device
Source: Streetwise Reports  (9/30/20)
Genetron Holdings Ltd. shares traded 25% higher after the company reported it has received Breakthrough Device Designation from the FDA for its blood-based next-generation sequencing test for early hepatocellular carcinoma detection. More >

Aptorum Shares Skyrocket Upon Launching Infectious Disease Liquid Biopsy Unit
Source: Streetwise Reports  (9/29/20)
Shares of Aptorum Group Ltd. traded nearly 300% higher after the company reported it launched an infectious disease liquid biopsy start-up subsidiary. More >

Bringing Order to Information Chaos Is a Necessity in the Age of COVID-19
Source: Streetwise Reports  (8/31/20)
Leonovus, a data storage and security technology firm, positions its software to enable healthcare groups to organize massive amounts of COVID/public health data. More >

Firm's Home Health Monitoring System Provides the 'Most Comprehensive Offering in the Telehealth Space'
Source: Streetwise Reports  (8/26/20)
As the Covid pandemic accelerates the adoption of telemedicine technology, Reliq Health Technologies' recent contracts represent exponential growth. More >

Fluidigm Shares Climb 34% After FDA Authorizes Saliva-Based COVID-19 Test
Source: Streetwise Reports  (8/26/20)
Fluidigm Corp. shares reached a new 52-week high after the firm reported the FDA granted Emergency Use Authorization for saliva-based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19. More >

Canadian Biotech Advances Antibodies, Diagnostics Programs in Q2/20
Source: Streetwise Reports  (8/14/20)
One highlight is ProMIS Neurosciences' development of a SARS CoV-2 antibody test. More >

$18.5 Billion Merger Could Mean Big Gains for These Five Tiny Telemedicine Stocks
Source: Matt Badiali for Streetwise Reports  (8/10/20)
Independent financial analyst Matt Badiali examines five small companies poised to profit as digital health becomes mainstream during the coronavirus pandemic. More >

US Immunology Firm Lands Government Contract, Raises Cash
Source: Streetwise Reports  (8/5/20)
These two CytoSorbents events are discussed in a Dawson James report. More >

Tech Firm Explains Key Feature of its Contact Tracing Solution
Source: Streetwise Reports  (8/5/20)
Loop Insights' technology lacks the adoption challenges that app-based solutions face. More >

Fulgent Genetics' Shares Reach New 52-Week High After Posting 105% Increase in Q2 Revenue
Source: Streetwise Reports  (8/5/20)
Shares of Fulgent Genetics traded 22% higher after the company reported it posted a record $17.1 million in Q2/20 revenue and completed a record 180,513 billable tests in the quarter. More >

Mobile Health Tech Firm Joins with US Healthcare Group to Bring Care Platform to 50,000 Patients
Source: Streetwise Reports  (8/4/20)
Reliq Health Technologies reported it has entered into a new contract with Diversified Healthcare Partners to provide its iUGO Care platform to more than 50,000 patients in three U.S. states. More >

Coverage Initiated on 'Emerging Colossus in Diagnostics and Life Science'
Source: Streetwise Reports  (7/29/20)
Meridian Bioscience's business segments, revenue and growth as well as COVID-19's positive impact on them are reviewed in an H.C. Wainwright & Co. report. More >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'
Source: Streetwise Reports  (7/22/20)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. More >

Cheap Valuation and Fastest Revenue Growth in Telemedicine? Analyst Says Yes.
Source: Peter Epstein for Streetwise Reports  (7/17/20)
In the time of Covid-19, Peter Epstein of Epstein Research breaks down the investment opportunity offered by CloudMD. More >

Virtual Healthcare Tech Firm's Contract in Puerto Rico Is Its Largest by 400%
Source: Streetwise Reports  (7/15/20)
Reliq Health Technologies' agreement with digiiMED makes its platform available to more than 200,000 patients. More >

Biotech Partners to Develop, Offer Alzheimer's Disease Tests
Source: Streetwise Reports  (7/13/20)
ProMIS Neurosciences and its collaborator make their relationship official with a joint venture agreement. More >

Preclinical COVID-19 Vaccine Data 'Encouraging'
Source: Streetwise Reports  (7/8/20)
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. More >

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX
Source: Streetwise Reports  (6/22/20)
Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. More >

Biotech Makes 'Significant Progress' Creating Highly Accurate COVID-19 Antibody Test
Source: Streetwise Reports  (6/17/20)
ProMIS Neurosciences states that the current version of the ProMIS-BCNI assay achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2, the coronavirus causing COVID-19. More >